| 000 | 01896 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517203449.0 | ||
| 264 | 0 | _c20191217 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a2041-4889 | ||
| 024 | 7 |
_a10.1038/s41419-018-0378-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, Tao-Tao | |
| 245 | 0 | 0 |
_aHydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. _h[electronic resource] |
| 260 |
_bCell death & disease _c03 2018 |
||
| 300 |
_a351 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin L _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHepatitis A Virus Cellular Receptor 1 _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxychloroquine _xmetabolism |
| 650 | 0 | 4 |
_aInflammasomes _xmetabolism |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNLR Family, Pyrin Domain-Containing 3 Protein _xmetabolism |
| 650 | 0 | 4 |
_aNeutrophil Infiltration _xdrug effects |
| 650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
| 700 | 1 | _aLv, Lin-Li | |
| 700 | 1 | _aPan, Ming-Ming | |
| 700 | 1 | _aWen, Yi | |
| 700 | 1 | _aWang, Bin | |
| 700 | 1 | _aLi, Zuo-Lin | |
| 700 | 1 | _aWu, Min | |
| 700 | 1 | _aWang, Feng-Mei | |
| 700 | 1 | _aCrowley, Steve D | |
| 700 | 1 | _aLiu, Bi-Cheng | |
| 773 | 0 |
_tCell death & disease _gvol. 9 _gno. 3 _gp. 351 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41419-018-0378-3 _zAvailable from publisher's website |
| 999 |
_c28141130 _d28141130 |
||